Epidermal Barrier in Atopic Dermatitis and Its Measurement by Transepidermal Water Loss Meter

1. ADDOR, F. A., TAKAOKA, R., RIVITTI, E. A. et al. Atopic dermatitis: correlation between non-damaged skin barrier function and disease activity. Int. J. Dermatol., 2012, 51, p. 672–676.

2. ADDOR, F. A., AOKI, V. Skin barrier in atopic dermatitis. An Bras Dermatol., 2010, 85, 2, p. 184–194.

3. BÖHME, M., SVENSSON, Å., KULL, I. et al. Hanifin’s and Rajka’s minor criteria for atopic dermatitis: which do 2-year-olds exhibit? Journal of the American Academy of Dermatology, 2000, 43, 5, p. 785–792.

4. CANDU, E., SCHMIDT, R., MELINO, G. The cornified envelope:a model of cell death in the skin. Nature Reviews Molecular Cell Biology, 2005, 6, 4, p. 328–340.

5. CHROMEJ, I. Atopický ekzém. 1. Vydanie, Banská Bystrica: Dali-BB, 2007, 240 s., ISBN 9788089090259.

6. DE JONGH, G. J., ZEEUWEN, P. L., KUCHAREKOVA, M. et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J. Invest. Dermatol., 2005, 125, 6, p. 1163–1173.

7. DI NARDO, A., WERTZ, P., GIANNETI, A. et al. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol-Stockh., 1998, 78, p. 27–30.

8. EGELRUD, T., LUNDSTRÖM, A. A chymotrypsin-like proteinase that may be involved in desquamation in plantar stratum corneum. Arch. Dermatol. Res., 1991, 283, 2, p. 108–112.

9. FARTASCH, M., BASSUKAS, I. D., DIEPGEN, T. L. Disturbed extruding mechanism of lamellar bodies in dry non eczematous skin of atopics. Br. J. Dermatol., 1992, 127, 3, p. 221–227.

10. GAN, S. Q. et al. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry, 1990, 29, 40, p. 9432–9440.

11. HANSSON, L., BÄCKMAN, A., NY, A. et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J. Invest. Dermatol., 2002, 118, 3, p. 444–449.

12. HARA, J., HIGUCHI, K., OKAMOTO, R. et al. High-Expression of Sphingomyelin Deacylase is an Important Determinant of Ceramide Deficiency Leading to Barrier Disruption in Atopic Dermatitis1. J. Invest. Dermatol., 2000, 115, 3, p. 406–413.

13. HEGYI, J. Využitie ultrasonografie v diagnostike kožných chorôb. Dermatol. Praxi, 2007, 1, 3, p. 102–103.

14. HOLM, E. A., Wulf, H. C., Thomassen, L. et al. Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema. J. Am. Acad. Dermatol., 2006, 55, 5, p. 772–780.

15. HORROBIN, D. F. Essential fatty acid metabolism and its modification in atopic eczema. Am. J. Clinic Nutr., 2000, 71, 1, p. 367–372.

16. IMOKAWA, G., ABE, A., JIN, K. et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol., 1991, 96, 4, p. 523–526.

17. IMOKAWA, G. A possible mechanism underlying the ceramide deficiency in atopic dermatitis: Expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. J. Dermatol. Sci., 2009, 55, 1, p. 1–9.

18. JENSEN, J. M., FÖLSTER-HOLST, R., BARANOWSKY, A. et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J. Invest. Dermatol., 2004, 122, 6, p. 1423–1431.

19. KIM, D. W., PARK, J. Y., NA, G. Y. et al. Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis. Int. J. Dermatol., 2006, 45, 6, p. 698–701.

20. LÖFFLER, H., EFFENDY, I. Skin susceptibility of atopic individuals. Contact Dermatitis, 1999, 40, 5, p. 239–242.

21. MÄGERT, H. J., KREUTZMANN, P., DRÖGEMÜLLER, K. et al. The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role. Eur. J. Med. Res., 2002, 7, 2, p. 49.

22. MATSUMOTO, M., SUGIURA, H., UEHARA, M. Skin barrier function in patients with completely healed atopic dermatitis. J. Dermatol. Sci., 2000, 23, 3, p. 178.

23. MIEDZOBRODZKI, J., KASZYCKI, P., BIALECKA, A. et al. Proteolytic activity of Staphylococcus aureus strains isolated from the colonized skin of patients with acute-phase atopic dermatitis. European Journal of Clinical Microbiology and Infectious Diseases, 2002, 21, 4, p. 269–276.

24. MURATA, Y., OGATA, J., HIGAKI, Y. et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J. Invest. Dermatol., 1996, 106, 6, p. 1242–1249.

25. OHNISHI, Y., OKINO, N., ITO, M. et al. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clinical and diagnostic laboratory immunology, 1999, 6, 1, p. 101–104.

26. OKAMOTO, R., ARIKAWA, J., ISHIBASHI, M. et al. Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. J. Lipid. Res., 2003, 44, 1, p. 93-102.

27. PINNAGODA, J., TUPKEK, R. A., AGNER, T. et al. Guidelines for transepidermal water loss (TEWL) measurement. Contact Dermatitis, 1990, 22, 3, p. 164–178.

28. PROKSCH, E., FOLSTER-HOLST, R., JANSEN, J. M. Skin barrier function, epidermal proliferation and differentiation in eczema. J. Dermatol. Sci., 2006, 43, 3, p. 159–169.

29. RESL, V., LEBA, M., RAMPL, I. Měření transepidermální ztráty vody (TEWL). Čs. Derm., 2008, roč. 83, č. 6, s. 319–324, ISSN: 0009-051481.

31. RESL, V. Bioinženýrské metody v dermatovenerologii I.  Přístrojové metody ke stanovení různých parametrů kůže. Čs. Derm., 2002, 77, 3, p. 133–138.

32. ROVENSKÝ, V., HANUŠ, M. Měření elektrické vodivosti jako metoda hodnocení barierové funkce kůže Čs. Derm., 1985, 60, 3, p. 183–188.

33. RESL, V., CETKOVSKÁ, P. et al, I. Profilometrie. Čs. Derm., 2006, 81 (3), p. 169–173.

34. SEIDENARI, S., GIUSTI, G. Objective assessment of the skin of children affected by atopic dermatitis: a study on pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm. Venereol. (Stockh)., 1995, 75, p. 429–433.

35. SEGUCHI, T., CHANG-YI, C., KUSUDA, S. et al. Decreased expression of filaggrin in atopic skin. Arch. Dermatol. Res., 1996, 288, 8, p. 442–446.

36. SCHÄFER, L., KRAGBALLE, K. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis. J. Invest. Dermatol., 1991, 96, 1, p. 10–15.

37. STEINERTD, P. M., MAREKOV, L. N. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J. Biol. Chem., 1995, 270, p. 17702–17711.

38. SUZUKI, Y., NOMURA, J., KOYAMA, J. et al. The role of proteases in stratum corneum: involvement in stratum corneum desquamation. Arch. Dermatol. Res., 1994, 286, 5, p. 249–253.

39. VASILOPOULOS, Y., CORK, M. J., MURPHY, R. et al. Genetic association between an AACC insertion in the 3′ UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J. Invest. Dermatol., 2003, 123, 1, p. 62–66.

40. YASUEDA, H., Mita, H., Akiyama, K. et al. Allergens from Dermatophagoides mites with chymotryptic activity. Clinical and experimental allergy. J. Brit. Soc. Allergy Clin. Immunol., 1993, 23, 5, p. 384.

41. WATANABE, M., TAGAMI, H., HORII, I. et al. Functional analyses of the superficial stratum corneum in atopic xerosis. Arch. Dermatol., 1991, 127, 11, p. 1689.

42. WERNER, Y. L. V. A., LINDBERG, M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Dermatol Venereol., 1985, 65, 2, p. 102.

43. WILLIAMS, H. C. Clinical practice. Atopic dermatitis. N. Engl. J. Med., 2005, 352, p. 2314–2324.